Melinda Wenner Moyer (@Lindy2350) is a science writer based in New York’s Hudson Valley. She is a visiting scholar at NYU’s Arthur L. Carter Journalism Institute and an Alicia Patterson fellow. Moyer writes a column for Slate and is a contributing editor at Scientific American. Her work has also appeared in the New York Times, Mother Jones, and a number of women’s magazines.
Melinda Wenner Moyer
From this contributor
When autistic people commit sexual crimes
Many first-time sex offenders on the spectrum may not understand the laws they break. How should their crimes be treated?
When autistic people commit sexual crimes
By
Melinda Wenner Moyer
17 July 2019 | 19 min read
How pregnancy may shape a child’s autism
Autism is predominantly genetic in origin, but a growing list of prenatal exposures for mother and baby may sway the odds.
How pregnancy may shape a child’s autism
By
Melinda Wenner Moyer
5 December 2018 | 17 min read
Explore more from The Transmitter
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
By
Angie Voyles Askham
27 January 2026 | 7 min read
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
By
Siddhant Pusdekar
27 January 2026 | 5 min read
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
FDA website no longer warns against bogus autism therapies, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 26 January.
By
Jill Adams
27 January 2026 | 2 min read